Risks of Stroke and Mortality in Atrial Fibrillation Patients Treated With Rivaroxaban and Warfarin

Oral anticoagulation therapy is standard of care for patients with nonvalvular atrial fibrillation to prevent stroke. This study compared rivaroxaban and warfarin for stroke and all-cause mortality risk reduction in a real-world setting. METHODS—: This retrospective cohort study (2011–2017) included...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Stroke
Glavni autori: Alberts, Mark, Chen, Yen-Wen, Lin, Jennifer H., Kogan, Emily, Twyman, Kathryn, Milentijevic, Dejan
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2020
Teme:
Original Contributions
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004448/
https://ncbi.nlm.nih.gov/pubmed/31888412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.119.025554
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items